Skip to main content
Erschienen in: Herz 6/2013

01.09.2013 | Main topic

Comorbid depression in heart failure

verfasst von: J. Wallenborn, C.E. Angermann

Erschienen in: Herz | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Heart failure (HF) is highly prevalent and associated with adverse outcomes and high costs. Compared with the general population, depression is up to five times more common in HF patients. Comorbid depression increases morbidity and mortality risk and health-care expenditures even further and decreases quality of life. Possible, often interrelated, mediators of these effects include biological, behavioral, and psychosocial factors. Screening instruments such as the self-administered PHQ-2 facilitate detection of patients at risk. Although antidepressants may improve psychological well-being, no positive effects on hard clinical endpoints have been demonstrated to date.
Literatur
1.
Zurück zum Zitat Konstam V, Moser DK, De Jong MJ (2005) Depression and anxiety in heart failure. J Card Fail 11(6):455–463PubMedCrossRef Konstam V, Moser DK, De Jong MJ (2005) Depression and anxiety in heart failure. J Card Fail 11(6):455–463PubMedCrossRef
2.
Zurück zum Zitat Rutledge T, Reis VA, Linke SE, Greenberg BH et al (2006) Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48(8):1527–1537PubMedCrossRef Rutledge T, Reis VA, Linke SE, Greenberg BH et al (2006) Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48(8):1527–1537PubMedCrossRef
3.
Zurück zum Zitat Vaccarino V, Kasl SV, Abramson J, Krumholz HM (2001) Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 38(1):199–205PubMedCrossRef Vaccarino V, Kasl SV, Abramson J, Krumholz HM (2001) Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 38(1):199–205PubMedCrossRef
4.
Zurück zum Zitat Parissis JT, Fountoulaki K, Paraskevaidis I, Kremastinos D (2005) Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches. Expert Opin Investig Drugs 14(5):567–577PubMedCrossRef Parissis JT, Fountoulaki K, Paraskevaidis I, Kremastinos D (2005) Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches. Expert Opin Investig Drugs 14(5):567–577PubMedCrossRef
5.
Zurück zum Zitat Sayers SL, Hanrahan N, Kutney A, Clarke SP et al (2007) Psychiatric comorbidity and greater hospitalization risk, longer length of stay, and higher hospitalization costs in older adults with heart failure. J Am Geriatr Soc 55(10):1585–1591PubMedCrossRef Sayers SL, Hanrahan N, Kutney A, Clarke SP et al (2007) Psychiatric comorbidity and greater hospitalization risk, longer length of stay, and higher hospitalization costs in older adults with heart failure. J Am Geriatr Soc 55(10):1585–1591PubMedCrossRef
6.
Zurück zum Zitat Jiang W, Kuchibhatla M, Clary GL, Cuffe MS et al (2007) Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J 154(1):102–108PubMedCrossRef Jiang W, Kuchibhatla M, Clary GL, Cuffe MS et al (2007) Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J 154(1):102–108PubMedCrossRef
7.
Zurück zum Zitat Faris R, Purcell H, Henein MY, Coats AJ (2002) Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail 4(4):541–551PubMedCrossRef Faris R, Purcell H, Henein MY, Coats AJ (2002) Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail 4(4):541–551PubMedCrossRef
8.
Zurück zum Zitat Jacob S, Sebastian JC, Abraham G (2003) Depression and congestive heart failure: are antidepressants underutilized? Eur J Heart Fail 5(3):399–400PubMedCrossRef Jacob S, Sebastian JC, Abraham G (2003) Depression and congestive heart failure: are antidepressants underutilized? Eur J Heart Fail 5(3):399–400PubMedCrossRef
9.
Zurück zum Zitat Moraska AR, Chamberlain AM, Shah ND, Vickers KS et al (2013) Depression, healthcare utilization, and death in heart failure: a community study. Circ Heart Fail 6(3):387–394PubMedCrossRef Moraska AR, Chamberlain AM, Shah ND, Vickers KS et al (2013) Depression, healthcare utilization, and death in heart failure: a community study. Circ Heart Fail 6(3):387–394PubMedCrossRef
10.
Zurück zum Zitat Angermann CE, Gelbrich G, Stork S, Schowalter M et al (2011) Somatic correlates of comorbid major depression in patients with systolic heart failure. Int J Cardiol 147(1):66–73PubMedCrossRef Angermann CE, Gelbrich G, Stork S, Schowalter M et al (2011) Somatic correlates of comorbid major depression in patients with systolic heart failure. Int J Cardiol 147(1):66–73PubMedCrossRef
11.
Zurück zum Zitat Faller H, Stork S, Schowalter M, Steinbuchel T et al (2007) Depression and survival in chronic heart failure: does gender play a role? Eur J Heart Fail 9(10):1018–1023PubMedCrossRef Faller H, Stork S, Schowalter M, Steinbuchel T et al (2007) Depression and survival in chronic heart failure: does gender play a role? Eur J Heart Fail 9(10):1018–1023PubMedCrossRef
12.
Zurück zum Zitat Jiang W, Krishnan R, Kuchibhatla M, Cuffe MS et al (2011) Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study). Am J Cardiol 107(4):545–551PubMedCrossRef Jiang W, Krishnan R, Kuchibhatla M, Cuffe MS et al (2011) Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study). Am J Cardiol 107(4):545–551PubMedCrossRef
13.
Zurück zum Zitat Sherwood A, Blumenthal JA, Trivedi R, Johnson KS et al (2007) Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 167(4):367–373PubMedCrossRef Sherwood A, Blumenthal JA, Trivedi R, Johnson KS et al (2007) Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 167(4):367–373PubMedCrossRef
14.
Zurück zum Zitat American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn (DSM-5). American Psychiatric Publishing, Arlington VA American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn (DSM-5). American Psychiatric Publishing, Arlington VA
15.
Zurück zum Zitat World Health Organization (1992) ICD-10 Classification of mental and behavioural disorders. Clinical descriptions and diagnostic guide- lines. World Health Organization, Geneva World Health Organization (1992) ICD-10 Classification of mental and behavioural disorders. Clinical descriptions and diagnostic guide- lines. World Health Organization, Geneva
16.
Zurück zum Zitat Lowe B, Grafe K, Zipfel S, Witte S et al (2004) Diagnosing ICD-10 depressive episodes: superior criterion validity of the Patient Health Questionnaire. Psychother Psychosom 73(6):386–390PubMedCrossRef Lowe B, Grafe K, Zipfel S, Witte S et al (2004) Diagnosing ICD-10 depressive episodes: superior criterion validity of the Patient Health Questionnaire. Psychother Psychosom 73(6):386–390PubMedCrossRef
17.
Zurück zum Zitat Lowe B, Kroenke K, Grafe K (2005) Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res 58(2):163–171PubMedCrossRef Lowe B, Kroenke K, Grafe K (2005) Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res 58(2):163–171PubMedCrossRef
18.
Zurück zum Zitat Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N et al (2008) Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 118(17):1768–1775PubMedCrossRef Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N et al (2008) Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 118(17):1768–1775PubMedCrossRef
19.
Zurück zum Zitat American Heart Association (2005) Heart disease and stroke statistics—2005 update. American Heart Association, Dallas American Heart Association (2005) Heart disease and stroke statistics—2005 update. American Heart Association, Dallas
20.
21.
Zurück zum Zitat Gottlieb SS, Khatta M, Friedmann E, Einbinder L et al (2004) The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 43(9):1542–1549PubMedCrossRef Gottlieb SS, Khatta M, Friedmann E, Einbinder L et al (2004) The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 43(9):1542–1549PubMedCrossRef
22.
Zurück zum Zitat Lossnitzer N, Herzog W, Störk S, Wild B et al (2013) Incidence rates and predictors of major and minor depression in patients with heart failure. Int J Cardiol 167(2):502–507PubMedCrossRef Lossnitzer N, Herzog W, Störk S, Wild B et al (2013) Incidence rates and predictors of major and minor depression in patients with heart failure. Int J Cardiol 167(2):502–507PubMedCrossRef
23.
Zurück zum Zitat Havranek EP, Spertus JA, Masoudi FA, Jones PG et al (2004) Predictors of the onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol 44(12):2333–2338PubMedCrossRef Havranek EP, Spertus JA, Masoudi FA, Jones PG et al (2004) Predictors of the onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol 44(12):2333–2338PubMedCrossRef
24.
Zurück zum Zitat Luijendijk HJ, Tiemeier H, Berg JF van den, Bleumink GS et al (2010) Heart failure and incident late-life depression. J Am Geriatr Soc 58(8):1441–1448PubMedCrossRef Luijendijk HJ, Tiemeier H, Berg JF van den, Bleumink GS et al (2010) Heart failure and incident late-life depression. J Am Geriatr Soc 58(8):1441–1448PubMedCrossRef
25.
Zurück zum Zitat Jiang W, Alexander J, Christopher E, Kuchibhatla M et al (2001) Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161(15):1849–1856PubMedCrossRef Jiang W, Alexander J, Christopher E, Kuchibhatla M et al (2001) Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161(15):1849–1856PubMedCrossRef
26.
Zurück zum Zitat Lett HS, Blumenthal JA, Babyak MA, Sherwood A et al (2004) Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 66(3):305–315PubMedCrossRef Lett HS, Blumenthal JA, Babyak MA, Sherwood A et al (2004) Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 66(3):305–315PubMedCrossRef
27.
Zurück zum Zitat Davidson KW, Rieckmann N, Lesperance F (2004) Psychological theories of depression: potential application for the prevention of acute coronary syndrome recurrence. Psychosom Med 66(2):165–173PubMedCrossRef Davidson KW, Rieckmann N, Lesperance F (2004) Psychological theories of depression: potential application for the prevention of acute coronary syndrome recurrence. Psychosom Med 66(2):165–173PubMedCrossRef
28.
Zurück zum Zitat Frasure-Smith N, Lesperance F, Habra M, Talajic M et al (2009) Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation 120(2):134–140 (3p following 40)PubMedCrossRef Frasure-Smith N, Lesperance F, Habra M, Talajic M et al (2009) Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation 120(2):134–140 (3p following 40)PubMedCrossRef
29.
Zurück zum Zitat Moraska AR, Chamberlain AM, Shah ND, Vickers KS et al (2013) Depression, healthcare utilization, and death in heart failure: a community study. Circ Heart Fail 6(3):387–394PubMedCrossRef Moraska AR, Chamberlain AM, Shah ND, Vickers KS et al (2013) Depression, healthcare utilization, and death in heart failure: a community study. Circ Heart Fail 6(3):387–394PubMedCrossRef
30.
Zurück zum Zitat Sullivan M, Simon G, Spertus J, Russo J (2002) Depression-related costs in heart failure care. Arch Intern Med 162(16):1860–1866PubMedCrossRef Sullivan M, Simon G, Spertus J, Russo J (2002) Depression-related costs in heart failure care. Arch Intern Med 162(16):1860–1866PubMedCrossRef
31.
Zurück zum Zitat Schowalter M, Gelbrich G, Stork S, Langguth JP et al (2013) Generic and disease-specific health-related quality of life in patients with chronic systolic heart failure: impact of depression. Clin Res Cardiol 102(4):269–278PubMedCrossRef Schowalter M, Gelbrich G, Stork S, Langguth JP et al (2013) Generic and disease-specific health-related quality of life in patients with chronic systolic heart failure: impact of depression. Clin Res Cardiol 102(4):269–278PubMedCrossRef
32.
Zurück zum Zitat Faller H, Stork S, Schuler M, Schowalter M et al (2009) Depression and disease severity as predictors of health-related quality of life in patients with chronic heart failure—a structural equation modeling approach. J Card Fail 15(4):286–292 e2PubMedCrossRef Faller H, Stork S, Schuler M, Schowalter M et al (2009) Depression and disease severity as predictors of health-related quality of life in patients with chronic heart failure—a structural equation modeling approach. J Card Fail 15(4):286–292 e2PubMedCrossRef
33.
Zurück zum Zitat Faller H, Steinbuchel T, Stork S, Schowalter M et al (2010) Impact of depression on quality of life assessment in heart failure. Int J Cardiol 142(2):133–137PubMedCrossRef Faller H, Steinbuchel T, Stork S, Schowalter M et al (2010) Impact of depression on quality of life assessment in heart failure. Int J Cardiol 142(2):133–137PubMedCrossRef
34.
Zurück zum Zitat Rozanski A, Blumenthal JA, Davidson KW, Saab PG et al (2005) The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 45(5):637–651PubMedCrossRef Rozanski A, Blumenthal JA, Davidson KW, Saab PG et al (2005) The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 45(5):637–651PubMedCrossRef
35.
Zurück zum Zitat Carney RM, Freedland KE, Veith RC (2005) Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 67(Suppl 1):S29–S33PubMedCrossRef Carney RM, Freedland KE, Veith RC (2005) Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 67(Suppl 1):S29–S33PubMedCrossRef
36.
Zurück zum Zitat Frasure-Smith N, Lesperance F, Irwin MR, Sauve C et al (2007) Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry 62(4):302–308PubMedCrossRef Frasure-Smith N, Lesperance F, Irwin MR, Sauve C et al (2007) Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry 62(4):302–308PubMedCrossRef
37.
Zurück zum Zitat Maes M, Ruckoanich P, Chang YS, Mahanonda N et al (2011) Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 35(3):769–783PubMedCrossRef Maes M, Ruckoanich P, Chang YS, Mahanonda N et al (2011) Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 35(3):769–783PubMedCrossRef
38.
Zurück zum Zitat Mahmoudi M, Curzen N, Gallagher PJ (2007) Atherogenesis: the role of inflammation and infection. Histopathology 50(5):535–546PubMedCrossRef Mahmoudi M, Curzen N, Gallagher PJ (2007) Atherogenesis: the role of inflammation and infection. Histopathology 50(5):535–546PubMedCrossRef
39.
Zurück zum Zitat Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29(2):201–217PubMedCrossRef Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29(2):201–217PubMedCrossRef
40.
Zurück zum Zitat Maes M, Bosmans E, Suy E, Vandervorst C et al (1990) Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology 24(3):115–120PubMedCrossRef Maes M, Bosmans E, Suy E, Vandervorst C et al (1990) Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology 24(3):115–120PubMedCrossRef
41.
Zurück zum Zitat Maes M, Scharpe S, Van Grootel L, Uyttenbroeck W et al (1992) Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord 24(3):183–192PubMedCrossRef Maes M, Scharpe S, Van Grootel L, Uyttenbroeck W et al (1992) Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord 24(3):183–192PubMedCrossRef
42.
Zurück zum Zitat Maes M, Delange J, Ranjan R, Meltzer HY et al (1997) Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 66(1):1–11PubMedCrossRef Maes M, Delange J, Ranjan R, Meltzer HY et al (1997) Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 66(1):1–11PubMedCrossRef
43.
Zurück zum Zitat Kop WJ, Gottdiener JS (2005) The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom Med 67(Suppl 1):S37–S41PubMedCrossRef Kop WJ, Gottdiener JS (2005) The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom Med 67(Suppl 1):S37–S41PubMedCrossRef
44.
Zurück zum Zitat Grippo AJ, Johnson AK (2002) Biological mechanisms in the relationship between depression and heart disease. Neurosci Biobehav Rev 26(8):941–962PubMedCrossRef Grippo AJ, Johnson AK (2002) Biological mechanisms in the relationship between depression and heart disease. Neurosci Biobehav Rev 26(8):941–962PubMedCrossRef
45.
Zurück zum Zitat Maier SF (2003) Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav Immun 17(2):69–85PubMedCrossRef Maier SF (2003) Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav Immun 17(2):69–85PubMedCrossRef
46.
Zurück zum Zitat Rugulies R (2002) Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med 23(1):51–61PubMedCrossRef Rugulies R (2002) Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med 23(1):51–61PubMedCrossRef
47.
Zurück zum Zitat Meijer A, Conradi HJ, Bos EH, Thombs BD et al (2011) Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 33(3):203–216PubMedCrossRef Meijer A, Conradi HJ, Bos EH, Thombs BD et al (2011) Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 33(3):203–216PubMedCrossRef
48.
Zurück zum Zitat Bane C, Hughes CM, McElnay JC (2006) The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease. Patient Educ Couns 60(2):187–193PubMedCrossRef Bane C, Hughes CM, McElnay JC (2006) The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease. Patient Educ Couns 60(2):187–193PubMedCrossRef
49.
Zurück zum Zitat Cohen HW, Gibson G, Alderman MH (2000) Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 108(1):2–8PubMedCrossRef Cohen HW, Gibson G, Alderman MH (2000) Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 108(1):2–8PubMedCrossRef
50.
Zurück zum Zitat Veien KT, Videbaek L, Schou M, Gustafsson F et al (2011) High mortality among heart failure patients treated with antidepressants. Int J Cardiol 146(1):64–67PubMedCrossRef Veien KT, Videbaek L, Schou M, Gustafsson F et al (2011) High mortality among heart failure patients treated with antidepressants. Int J Cardiol 146(1):64–67PubMedCrossRef
51.
Zurück zum Zitat O’Connor CM, Jiang W, Kuchibhatla M, Mehta RH et al (2008) Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med 168(20):2232–2237CrossRef O’Connor CM, Jiang W, Kuchibhatla M, Mehta RH et al (2008) Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med 168(20):2232–2237CrossRef
52.
Zurück zum Zitat Woltz PC, Chapa DW, Friedmann E, Son H et al (2012) Effects of interventions on depression in heart failure: a systematic review. Heart Lung 41(5):469–483PubMedCrossRef Woltz PC, Chapa DW, Friedmann E, Son H et al (2012) Effects of interventions on depression in heart failure: a systematic review. Heart Lung 41(5):469–483PubMedCrossRef
53.
Zurück zum Zitat O’Connor CM, Jiang W, Kuchibhatla M, Silva SG et al (2010) Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 56(9):692–699CrossRef O’Connor CM, Jiang W, Kuchibhatla M, Silva SG et al (2010) Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 56(9):692–699CrossRef
54.
Zurück zum Zitat Angermann CE, Gelbrich G, Stork S, Fallgatter A et al (2007) Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail 9(12):1212–1222PubMedCrossRef Angermann CE, Gelbrich G, Stork S, Fallgatter A et al (2007) Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail 9(12):1212–1222PubMedCrossRef
55.
Zurück zum Zitat Cleland JG, Louis AA, Rigby AS, Janssens U et al (2005) Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol 45(10):1654–1664PubMedCrossRef Cleland JG, Louis AA, Rigby AS, Janssens U et al (2005) Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol 45(10):1654–1664PubMedCrossRef
56.
Zurück zum Zitat Angermann CE, Stork S, Gelbrich G, Faller H et al (2012) Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail 5(1):25–35PubMedCrossRef Angermann CE, Stork S, Gelbrich G, Faller H et al (2012) Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail 5(1):25–35PubMedCrossRef
57.
Zurück zum Zitat Takeda A, Taylor SJ, Taylor RS, Khan F et al (2012) Clinical service organisation for heart failure. Cochrane Database Syst Rev 9:CD002752PubMed Takeda A, Taylor SJ, Taylor RS, Khan F et al (2012) Clinical service organisation for heart failure. Cochrane Database Syst Rev 9:CD002752PubMed
58.
Zurück zum Zitat Doughty RN, Wright SP, Pearl A, Walsh HJ et al (2002) Randomized, controlled trial of integrated heart failure management: the Auckland Heart Failure Management Study. Eur Heart J 23(2):139–146PubMedCrossRef Doughty RN, Wright SP, Pearl A, Walsh HJ et al (2002) Randomized, controlled trial of integrated heart failure management: the Auckland Heart Failure Management Study. Eur Heart J 23(2):139–146PubMedCrossRef
59.
Zurück zum Zitat Jaarsma T, Wal MH van der, Lesman-Leegte I, Luttik ML et al (2008) Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med 168(3):316–324PubMedCrossRef Jaarsma T, Wal MH van der, Lesman-Leegte I, Luttik ML et al (2008) Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med 168(3):316–324PubMedCrossRef
60.
Zurück zum Zitat Weinberger M, Oddone EZ, Henderson WG (1996) Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on primary care and hospital readmission. N Engl J Med 334(22):1441–1447PubMedCrossRef Weinberger M, Oddone EZ, Henderson WG (1996) Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on primary care and hospital readmission. N Engl J Med 334(22):1441–1447PubMedCrossRef
61.
Zurück zum Zitat Koehler F, Winkler S, Schieber M, Sechtem U et al (2012) Telemedicine in heart failure: pre-specified and exploratory subgroup analyses from the TIM-HF trial. Int J Cardiol 161(3):143–150PubMedCrossRef Koehler F, Winkler S, Schieber M, Sechtem U et al (2012) Telemedicine in heart failure: pre-specified and exploratory subgroup analyses from the TIM-HF trial. Int J Cardiol 161(3):143–150PubMedCrossRef
62.
Zurück zum Zitat Jaarsma T, Lesman-Leegte I, Hillege HL, Veeger NJ et al (2010) Depression and the usefulness of a disease management program in heart failure: insights from the COACH (Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure) study. J Am Coll Cardiol 55(17):1837–1843PubMedCrossRef Jaarsma T, Lesman-Leegte I, Hillege HL, Veeger NJ et al (2010) Depression and the usefulness of a disease management program in heart failure: insights from the COACH (Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure) study. J Am Coll Cardiol 55(17):1837–1843PubMedCrossRef
63.
Zurück zum Zitat Gelbrich G, Störk S, Kreissl S, Faller H, Prettin C et al (2013) Differential effects of structured collaborative disease management on mortality and morbidity in systolic heart failure patients with or without co-morbid major depressive symptoms in the Interdisciplinary Network for Heart Failure (INH) Study. J Am Coll Cardiol (in press) Gelbrich G, Störk S, Kreissl S, Faller H, Prettin C et al (2013) Differential effects of structured collaborative disease management on mortality and morbidity in systolic heart failure patients with or without co-morbid major depressive symptoms in the Interdisciplinary Network for Heart Failure (INH) Study. J Am Coll Cardiol (in press)
64.
Zurück zum Zitat Blumenthal JA, Babyak MA, O’Connor C, Keteyian S et al (2012) Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA 308(5):465–474PubMedCrossRef Blumenthal JA, Babyak MA, O’Connor C, Keteyian S et al (2012) Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA 308(5):465–474PubMedCrossRef
65.
Zurück zum Zitat McMurray JJ, Adamopoulos S, Anker SD, Auricchio A et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847PubMedCrossRef McMurray JJ, Adamopoulos S, Anker SD, Auricchio A et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847PubMedCrossRef
Metadaten
Titel
Comorbid depression in heart failure
verfasst von
J. Wallenborn
C.E. Angermann
Publikationsdatum
01.09.2013
Verlag
Urban & Vogel
Erschienen in
Herz / Ausgabe 6/2013
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-013-3886-z

Weitere Artikel der Ausgabe 6/2013

Herz 6/2013 Zur Ausgabe

Aktuelle Kardiologie

Aktuelle Kardiologie

CME Zertifizierte Fortbildung

Erwachsene mit angeborenen Herzfehlern

So beeinflussen Herzinfarkte auf lange Sicht die Sterblichkeit

20.06.2024 ST-Hebungsinfarkt Nachrichten

Wie hoch ist bei Patienten, die nach einem ST-Hebungs-Myokardinfarkt die initiale Hochrisikophase überleben, auf lange Sicht das Sterberisiko? Eine Studie aus Dänemark liefert dazu nun aufschlussreiche Daten.

Protonenpumpenhemmer stoppt Arrhythmie

20.06.2024 Protonenpumpenhemmstoffe Nachrichten

Wenn Nervenfasern aus dem Magen und dem Herzen im Gehirn dicht beieinander liegen, kann auch mal etwas schiefgehen: So lässt sich erklären, weshalb Schmerzen durch einen Magentumor bei einem Mann eine ventrikuläre Extrasystolie auslösen – und PPI diese beenden.

Ob Apixaban nützt oder schadet, entscheidet der CHA2DS2-VASc-Score

20.06.2024 Therapie des Vorhofflimmerns Nachrichten

Patienten mit subklinischem Vorhofflimmern tragen ein erhöhtes Risiko für Schlaganfälle. Da stellt sich die Frage nach einer medikamentösen Antikoagulation. Offenbar hängt es aber vom CHA2DS2-VASc-Score ab, ob die Gabe von Apixaban von Vorteil ist.

Wie SGLT2-Hemmer es schaffen, die Mortalität zu reduzieren

20.06.2024 Kardiologische Therapie Nachrichten

SGLT2-Hemmer verhindern keine Herzinfarkte oder Schlaganfälle. Aber sie reduzieren die kardiovaskuläre Mortalität bei einem breiten Spektrum von Patienten. Wie sie das schaffen, verdeutlicht eine Metaanalyse von Daten aus elf randomisierten Studien.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.